Given the pathogenic role of dysregulated cGAS-STING signaling in autoimmune disorders, targeting TRIM21’s E3 ubiquitin ligase activity could open new avenues for developing precision therapeutics to modulate this pathway in SLE and related conditions. The gene discussed is STING1; the disease is systemic lupus erythematosus.